Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
PaperCitations, authors & open-access status
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 876 citations, 2018 year and green oa status.
876
Citations
2018
Year
green
OA Status